RJ

Ramakanta Jena

Director Director DIN 00534471
DIN 00534471 First appointment Mar 2004 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2004
Shareholding value Locked Premium profile

About Ramakanta Jena

Ramakanta Jena has 22 years in corporate governance. Formerly with 1 company, such as Oro Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00534471
Primary Designation Director
First Appointment 09 Mar 2004
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Oro Pharmaceuticals Private Limited U24232OR2004PTC007517
Director 09 Mar 2004 2004 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Oro Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ramakanta Jena

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramakanta Jena

Ramakanta Jena has 22 years in corporate governance. Formerly with 1 company, such as Oro Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Ramakanta Jena is associated with 0 companies as a director.

Ramakanta Jena has expertise in General Business.

Ramakanta Jena has 22 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available